None listed
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Imedrix Systems Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Participants with normal BP, prehypertension, stage 1 hypertension, and stage 2 hypertension. Participants who provide voluntary informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: Pregnant women, paediatric, or elderly individuals above the age of 65. Participants with present arrhythmias.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bland-Altman plot analysis will determine the Limits of Agreement (LoA) and their confidence intervals (CI). Agreement is concluded if the confidence intervals lie within the predefined boundary of ?7 mmHg.Timepoint: Measured at baseline and again within 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean differences in systolic & diastolic BP over repeated measurements using Bland-Altman analysis.Timepoint: Measured at baseline & again within 4 weeks;Accuracy of BP Band in distinguishing BP ranges (normal, prehypertension, stage 1 & 2 hypertension).Timepoint: Measured at baseline & again within 4 weeks;Participant adherence rates & feedback on usability through structured surveys.Timepoint: Measured at baseline & again within 4 weeks | — |
Countries
India
Contacts
Public ContactDr Akansha Kumari
Centre for Chronic Disease Control (CCDC)
Outcome results
None listed